Cardiac cachexia is a multifaceted and severe syndrome characterized by the involuntary weight loss, muscle wasting, and debility seen in individuals grappling with chronic heart failure. This syndrome extends beyond simple weight reduction, involving a profound depletion of both lean body mass and fat reserves. Its management presents a considerable challenge in the context of heart failure, often resulting in heightened morbidity and mortality rates. The intricate mechanisms underlying cardiac cachexia encompass a intricate interplay of inflammatory processes, hormonal imbalances, and metabolic disruptions. Clinically, individuals afflicted by cardiac cachexia witness a decline in their functional capacity, coupled with a compromised quality of life. Approaches to managing this syndrome typically necessitate a multidisciplinary strategy, emphasizing nutritional support, exercise rehabilitation, and addressing the root causes of heart failure. Ongoing research delving into the pathophysiology and treatment avenues for cardiac cachexia aspires to deepen our comprehension and enhance the prognosis for those affected by this incapacitating syndrome.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States